Ludo M. Evers

933 total citations
9 papers, 706 citations indexed

About

Ludo M. Evers is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Ludo M. Evers has authored 9 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Immunology. Recurrent topics in Ludo M. Evers's work include Chronic Lymphocytic Leukemia Research (3 papers), Cell death mechanisms and regulation (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Ludo M. Evers is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Cell death mechanisms and regulation (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Ludo M. Evers collaborates with scholars based in Netherlands and United States. Ludo M. Evers's co-authors include Marinus H. J. van Oers, Robert M. J. Keehnen, Patrick W.B. Derksen, Steven T. Pals, Marcel Spaargaren, J. G. van der Schroeff, Johannes L. Bos, Johannes M. F. G. Aerts, Carla E. M. Hollak and René A. W. van Lier and has published in prestigious journals such as Blood, European Journal of Immunology and Journal of Investigative Dermatology.

In The Last Decade

Ludo M. Evers

9 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ludo M. Evers Netherlands	8	372	210	152	144	143	9	706
Gaia Roversi Italy	13	592 1.6×	139 0.7×	52 0.3×	48 0.3×	62 0.4×	18	960
Siân Rizzo United Kingdom	15	601 1.6×	91 0.4×	167 1.1×	179 1.2×	111 0.8×	25	1.1k
Liliana Terrin Italy	13	322 0.9×	38 0.2×	205 1.3×	43 0.3×	98 0.7×	21	707
Hirotsugu Hino Japan	13	198 0.5×	77 0.4×	26 0.2×	31 0.2×	105 0.7×	42	552
John R. Spaull United Kingdom	14	208 0.6×	44 0.2×	74 0.5×	47 0.3×	26 0.2×	17	878
Veronica Martini Italy	19	281 0.8×	54 0.3×	33 0.2×	102 0.7×	308 2.2×	41	740
J-Y Chen Taiwan	10	384 1.0×	77 0.4×	39 0.3×	43 0.3×	28 0.2×	12	914
A S Worobec United States	7	242 0.7×	130 0.6×	165 1.1×	181 1.3×	163 1.1×	8	1.1k
Yujun Sheng China	15	165 0.4×	113 0.5×	61 0.4×	21 0.1×	31 0.2×	56	724
Isidore Tepler United States	7	439 1.2×	47 0.2×	27 0.2×	182 1.3×	57 0.4×	8	947

Countries citing papers authored by Ludo M. Evers

Since Specialization

Citations

This map shows the geographic impact of Ludo M. Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludo M. Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludo M. Evers more than expected).

Fields of papers citing papers by Ludo M. Evers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludo M. Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludo M. Evers. The network helps show where Ludo M. Evers may publish in the future.

Co-authorship network of co-authors of Ludo M. Evers

This figure shows the co-authorship network connecting the top 25 collaborators of Ludo M. Evers. A scholar is included among the top collaborators of Ludo M. Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludo M. Evers. Ludo M. Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kater, Arnon P., Sabina Kersting, Yvette van Norden, et al.. (2018). Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL. Blood Advances. 2(24). 3566–3571. 20 indexed citations

Nur, Erfan, Dees P. M. Brandjes, Tom Teerlink, et al.. (2012). N-acetylcysteine reduces oxidative stress in sickle cell patients. Annals of Hematology. 91(7). 1097–1105. 67 indexed citations

Hoogeboom, Robbert, K P van Kessel, Thera A.M. Wormhoudt, et al.. (2011). Identification of a Novel B-CLL Subset Expressing Mutated Stereotyped B-Cell Receptors with Specificity for Yeast Mannan. Blood. 118(21). 623–623. 1 indexed citations

Kater, Arnon P., Ludo M. Evers, Ester B. M. Remmerswaal, et al.. (2004). CD40 stimulation of B‐cell chronic lymphocytic leukaemia cells enhances the anti‐apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T‐lymphocyte attack. British Journal of Haematology. 127(4). 404–415. 64 indexed citations

Eldering, Eric, Ingrid A. M. Derks, Ludo M. Evers, et al.. (2004). Apoptosis via the B cell antigen receptor requires Bax translocation and involves mitochondrial depolarization, cytochrome C release, and caspase‐9 activation. European Journal of Immunology. 34(7). 1950–1960. 39 indexed citations

Derksen, Patrick W.B., Robert M. J. Keehnen, Ludo M. Evers, et al.. (2002). Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood. 99(4). 1405–1410. 223 indexed citations

Hollak, Carla E. M., et al.. (1997). Elevated Levels of M-CSF, sCD14 and IL8 in Type 1 Gaucher Disease. Blood Cells Molecules and Diseases. 23(2). 201–212. 120 indexed citations

Schothorst, A.A., et al.. (1990). Pyrimidine Dimer Induction and Repair in Cultured Human Skin Keratinocytes or Melanocytes After Irradiation with Monochromatic Ultraviolet Radiation. Journal of Investigative Dermatology. 96(6). 916–920. 31 indexed citations

Schroeff, J. G. van der, et al.. (1990). Ras Oncogene Mutations in Basal Cell Carcinomas and Squamous Cell Carcinomas of Human Skin. Journal of Investigative Dermatology. 94(4). 423–425. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact